219 related articles for article (PubMed ID: 29755679)
1. microRNA profiles in urine by next-generation sequencing can stratify bladder cancer subtypes.
Pardini B; Cordero F; Naccarati A; Viberti C; Birolo G; Oderda M; Di Gaetano C; Arigoni M; Martina F; Calogero RA; Sacerdote C; Gontero P; Vineis P; Matullo G
Oncotarget; 2018 Apr; 9(29):20658-20669. PubMed ID: 29755679
[TBL] [Abstract][Full Text] [Related]
2. Combined miRNA and SERS urine liquid biopsy for the point-of-care diagnosis and molecular stratification of bladder cancer.
Moisoiu T; Dragomir MP; Iancu SD; Schallenberg S; Birolo G; Ferrero G; Burghelea D; Stefancu A; Cozan RG; Licarete E; Allione A; Matullo G; Iacob G; Bálint Z; Badea RI; Naccarati A; Horst D; Pardini B; Leopold N; Elec F
Mol Med; 2022 Apr; 28(1):39. PubMed ID: 35365098
[TBL] [Abstract][Full Text] [Related]
3. A urinary microRNA (miR) signature for diagnosis of bladder cancer.
Hofbauer SL; de Martino M; Lucca I; Haitel A; Susani M; Shariat SF; Klatte T
Urol Oncol; 2018 Dec; 36(12):531.e1-531.e8. PubMed ID: 30322728
[TBL] [Abstract][Full Text] [Related]
4. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C
Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.
Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E
BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191
[TBL] [Abstract][Full Text] [Related]
6. Cell-free microRNA expression signatures in urine serve as novel noninvasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
Du L; Jiang X; Duan W; Wang R; Wang L; Zheng G; Yan K; Wang L; Li J; Zhang X; Pan H; Yang Y; Wang C
Oncotarget; 2017 Jun; 8(25):40832-40842. PubMed ID: 28388561
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression profiling in bladder cancer: the challenge of next-generation sequencing in tissues and biofluids.
Matullo G; Naccarati A; Pardini B
Int J Cancer; 2016 May; 138(10):2334-45. PubMed ID: 26489968
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
[TBL] [Abstract][Full Text] [Related]
9. Small Non-Coding RNA Profiling in Plasma Extracellular Vesicles of Bladder Cancer Patients by Next-Generation Sequencing: Expression Levels of miR-126-3p and piR-5936 Increase with Higher Histologic Grades.
Sabo AA; Birolo G; Naccarati A; Dragomir MP; Aneli S; Allione A; Oderda M; Allasia M; Gontero P; Sacerdote C; Vineis P; Matullo G; Pardini B
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32527011
[TBL] [Abstract][Full Text] [Related]
10. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
11. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
[TBL] [Abstract][Full Text] [Related]
12. LC-MS metabolomics of urine reveals distinct profiles for non-muscle-invasive and muscle-invasive bladder cancer.
Oto J; Fernández-Pardo Á; Roca M; Plana E; Cana F; Herranz R; Pérez-Ardavín J; Vera-Donoso CD; Martínez-Sarmiento M; Medina P
World J Urol; 2022 Oct; 40(10):2387-2398. PubMed ID: 36057894
[TBL] [Abstract][Full Text] [Related]
13. Identification of miR-29c-3p as a Robust Normalizer for Urine microRNA Studies in Bladder Cancer.
Oto J; Plana E; Fernández-Pardo Á; Cana F; Martínez-Sarmiento M; Vera-Donoso CD; España F; Medina P
Biomedicines; 2020 Oct; 8(11):. PubMed ID: 33105660
[TBL] [Abstract][Full Text] [Related]
14. Analysis of serum genome-wide microRNAs for breast cancer detection.
Wu Q; Wang C; Lu Z; Guo L; Ge Q
Clin Chim Acta; 2012 Jul; 413(13-14):1058-65. PubMed ID: 22387599
[TBL] [Abstract][Full Text] [Related]
15. The MicroRNA Prediction Models as Ancillary Diagnosis Biomarkers for Urothelial Carcinoma in Patients With Chronic Kidney Disease.
Li AL; Chou CY; Chen CL; Wu KL; Lin SC; Chen HC; Wang MC; Chang CC; Hsu BG; Wu MS; Ma N; Huang CC
Front Med (Lausanne); 2021; 8():726214. PubMed ID: 34660637
[TBL] [Abstract][Full Text] [Related]
16. Using microRNA profiling in urine samples to develop a non-invasive test for bladder cancer.
Mengual L; Lozano JJ; Ingelmo-Torres M; Gazquez C; Ribal MJ; Alcaraz A
Int J Cancer; 2013 Dec; 133(11):2631-41. PubMed ID: 23686449
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA Expression can be a Promising Strategy for the Detection of Barrett's Esophagus: A Pilot Study.
Bansal A; Hong X; Lee IH; Krishnadath KK; Mathur SC; Gunewardena S; Rastogi A; Sharma P; Christenson LK
Clin Transl Gastroenterol; 2014 Dec; 5(12):e65. PubMed ID: 25502391
[TBL] [Abstract][Full Text] [Related]
18. UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria.
Kim WT; Jeong P; Yan C; Kim YH; Lee IS; Kang HW; Kim YJ; Lee SC; Kim SJ; Kim YT; Moon SK; Choi YH; Kim IY; Yun SJ; Kim WJ
Oncotarget; 2016 Sep; 7(36):58193-58202. PubMed ID: 27528424
[TBL] [Abstract][Full Text] [Related]
19. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
20. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]